| abstract |
The present invention provides synthesis, pharmaceutically acceptable formulations and uses of compounds in accordance with Formula IA or Formula TB, as well as stereoisomers, tautomers or pharmaceutically acceptable salts thereof. The inventive Formula IA and Formula TB compounds are inhibitors of Mnk and find utility in any number of therapeutic applications, including but not limited to treatment of inflammation and various cancers. |